LUCD logo

LUCD
Lucid Diagnostics Inc

1,761
Mkt Cap
$145.26M
Volume
638,293.00
52W High
$1.80
52W Low
$0.7501
PE Ratio
-1.18
LUCD Fundamentals
Price
$1.06
Prev Close
$1.06
Open
$1.06
50D MA
$1.12
Beta
0.62
Avg. Volume
1.18M
EPS (Annual)
-$1.05
P/B
-4.88
Rev/Employee
$60,361.11
Loading...
Loading...
News
all
press releases
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree PR Newswire NEW YORK, Nov. 20, 2025...
PR Newswire·5d ago
News Placeholder
More News
News Placeholder
Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Recommendation of "Moderate Buy" by Brokerages
Lucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the five research firms that are currently covering the stock...
MarketBeat·6d ago
News Placeholder
Needham & Company LLC Reaffirms Buy Rating for Lucid Diagnostics (NASDAQ:LUCD)
Needham & Company LLC reissued a "buy" rating and set a $3.00 target price on shares of Lucid Diagnostics in a research report on Thursday...
MarketBeat·11d ago
News Placeholder
Lucid Diagnostics (NASDAQ:LUCD) Announces Earnings Results
Lucid Diagnostics (NASDAQ:LUCD - Get Free Report) released its earnings results on Wednesday. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by...
MarketBeat·11d ago
News Placeholder
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and...
PR Newswire·12d ago
News Placeholder
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire NEW YORK, Nov. 13, 2025...
PR Newswire·12d ago
News Placeholder
Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates
Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -66.67% and -6.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·13d ago
News Placeholder
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire NEW...
PR Newswire·13d ago
News Placeholder
908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates
908 Devices (MASS) delivered earnings and revenue surprises of -15.38% and +3.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
Sensus Healthcare, Inc. (SRTS) Reports Q3 Loss, Tops Revenue Estimates
Sensus Healthcare (SRTS) delivered earnings and revenue surprises of +50.00% and +48.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·18d ago

Latest LUCD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.